STC 8123
Alternative Names: STC-8123Latest Information Update: 20 Apr 2022
Price :
$50 *
At a glance
- Originator Schrodinger
- Class Antineoplastics; Small molecules
- Mechanism of Action WEE1 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Gynaecological cancer; Solid tumours
Most Recent Events
- 12 Apr 2022 Preclinical trials in Gynaecological cancer in USA (PO), prior to April 2022 (Schrodinger pipeline, April 2022)
- 12 Apr 2022 Preclinical trials in Solid tumours in USA (PO), prior to April 2022 (Schrodinger pipeline, April 2022)
- 12 Apr 2022 Pharmacodynamics, pharmacokinetics and adverse events data from preclinical trials in Solid tumours released by Schrodinger